Alterome
San Diego, US · 5 known investors
Alterome is a clinical-stage precision oncology company developing small molecule therapies targeting mutant KRAS and AKT E17K in cancers including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancer.
Founders & leadership
EA
Eric A. MurphyExecutive Officer, Director, Promoter
TS
Thilo SchroederDirector
RB
Ryan B. CorcoranDirector, Promoter
CG
Carl GordonDirector
AG
Arjun GoyalDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$63.8MraisedJan 2022 · 9 investors · BiotechnologyRule 506(b)
▶$63.8MraisedJan 2022 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric A. MurphyExecutive Officer, Director, Promoter
- Thilo SchroederDirector
- Ryan B. CorcoranDirector, Promoter
- Carl GordonDirector
- Arjun GoyalDirector
- Offering amount
- $63.8M
- Amount sold
- $63.8M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · 2026
- Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · 2026
- Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · 2026